Episode 3: Rejuve On The Scientific Conquest of Death

The Mindplex Podcast

Send us a text

The Mindplex Podcast is hosted by Ben Goertzel, Lisa Rein, and Grace Robot.
The latest Mindplex Podcast Episode 3: On The Scientific Conquest of Death, takes a deep dive into Rejuve.AI and Rejuve.BIO, and how Rejuve.BIO’s cutting-edge Methuselah Fly research strategies complement Rejuve.AI’s techniques for developing personalized and “precision-based” anti-aging therapies. Rejuve.AI and Rejuve.BIO’s unique approach is not only aimed at curing aging but also at making sure that these anti-aging therapies are available for all — not just the rich.
Episode 3 Podcast Guests:
-Jasmine Smith, CEO of Rejuve.AI
-Michael Duncan, PA-C, Chief Science Officer Rejuve.BIO & Director of Clinical Research, Rejuve.AI
-Deborah Duong, CTO of Rejuve.AI
Episode 3 takes it for granted that extending the human lifespan is a positive goal, which gives Ben and the podcast guests an opportunity to explore what it means to extend the human lifespan by:
Recognizing aging as a disease,
Researching and isolating all of the various causes and contributors to ‘old age’ and death,
Create therapies to address those causes one by one,
Gradually extend the healthy human life span (aka healthspan),
With the eventual goal of postponing death indefinitely.
More about Rejuve.AI and Rejuve.BIO
Rejuve.AI, a spin-off of SingularityNET, is the world’s first decentralized AI longevity research network, bringing together blockchain, artificial intelligence, and longevity-focused research to increase human healthspan dramatically. Rejuve.AI’s mission is to decentralize the contribution of health data, which will enable and accelerate discoveries for advanced longevity therapies — and make the therapies available and affordable to all who want them. Most critically, Rejuve.AI is committed to fairly compensating the data contributors who made these discoveries possible and enabling them to maintain control of their data — forever.
Rejuve Biotech is a partner company to Rejuve.AI and is building an innovative AI-powered drug discovery and development platform. The project is developing a translational medicine service that combines an in-house model organism population with a unique AI-based analytical platform. The platform combines state-of-the-art machine learning and artificial general intelligence methods with a continuously updated biomedical knowledge graph integrating human and model organism databases. The Rejuve Bio Flybase (fly genetics Atomspace database) and longevity drug prediction and discovery engines will be some of the first use cases of the OpenCog Hyperon AGI framework.
The Rejuve Biotech animal model of choice is the long-lived Methuselah Fly, a type of Drosophila melanogaster (fruit fly), selectively bred over hundreds of generations to live at least 5 times longer than wild-type flies. These flies offer an expedited mode for generational longevity studies and for early evaluation of potential therapy candidates — faster, less expensive, and more scalable than human or other animal models.
FOLLOW Mindplex Podcast:🔽
🔹 WEBSITE → https://mindplex.ai
🔹 Mindplex News → https://magazine.mindplex.ai/news/
🔹 Mindplex TWITTER → https://twitter.com/Mindplex_ai
🔹 FACEBOOK → https://www.facebook.com/MindplexAI/
🔹 YOUTUBE → https://www.youtube.com/@mindplexpodcast
🔹 Spotify → https://open.spotify.com/show/3RbGNlj9SX8rYOVbln